|
|||||
A new federal grant supports expansion of a research and development center developing techniques to make the manufacture and integration of microfluidic, or lab-on-a-chip, devices easier and less expensive. . . . → Read More: NSF Supports Expanding Lab-On-Chip Integration, Manufacturing Center 
Experimental treatments with engineered RNA are shown in lab animals to reduce symptoms of preeclampsia, a disorder causing high blood pressure in pregnant women. . . . → Read More: RNA Therapy Helps Reduce Preeclampsia Symptoms 
Final results from a clinical trial show a preventive treatment desensitizes children and adolescents with peanut allergies against reaction-causing proteins in peanuts for one year. . . . → Read More: Trial Shows Treatment Prevents Peanut Allergy Reactions 
An initiative developing a contact lens that measures blood glucose levels in tear fluid is now on hold, according to Verily Life Sciences, a division of Alphabet, the parent company of Google. . . . → Read More: Update – Verily Suspends Glucose-Sensing Contact Lens Project 
Plant scientists in the U.K. and Australia are making available to their colleagues experimental techniques that speed-up breeding cycles for more commercial crop varieties. . . . → Read More: Faster Crop Breeding Techniques Made Available to Other Scientists 
A clinical trial to test a tiny implanted pellet containing a non-opioid pain killer began treating participants to relieve leg and back pain from sciatica. . . . → Read More: Trial Testing Non-Opioid Pellet Implant for Sciatica Pain 
A new clinical trial is testing a diabetes management program that includes Internet-connected glucose meters and one-on-one coaching against smartphone-enabled glucose meters alone. . . . → Read More: Trial Tests Diabetes Mgmt. Program vs. Smartphone Glucose Meter 
Synthetic antibodies derived from survivors of Ebola infections are shown to be quick and simple to develop, and in lab mice to provide long-term protection against against Ebola viruses. . . . → Read More: DNA-Encoded Synthetic Antibodies Protect Against Ebola 
Two biotechnology companies developing engineered viruses as cancer therapies plan to create personalized treatments for solid tumors with viruses that harness the immune system. . . . → Read More: Biotechs to Develop Personal Cancer-Killing Virus Vaccines 
A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells. . . . → Read More: RNA Therapeutics Company Raises $30M in First Venture Round |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
